Olivier Lantz

33.6k citations

213 papers · 16.9k indexed · 7 hit papers · h-index 65

Impact in

Immunology top 0.05%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
Oncology top 0.5%
- CAR-T cell therapy research

Papers in

Transplantation 20
- Renal Transplantation Outcomes and Treatments 19
Immunology 142
- Immune Cell Function and Interaction 109
- T-cell and B-cell Immunology 93
- Immunotherapy and Immune Responses 59
- IL-33, ST2, and ILC Pathways 18

Co-authors: Albert Bendelac Emmanuel Treiner Livine Duban Emmanuel Martin Lionel Le Bourhis Claire Soudais Florence Tilloy Virginie Prémel
Journals: The Journal of Immunology (15 papers)The Journal of Experimental Medicine (11 papers)Cancer Research (9 papers)European Journal of Immunology (9 papers)Journal of Clinical Oncology (7 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Olivier Lantz

210 papers receiving 16.8k citations

Hit Papers

7 papers align trajectories log scale

Antimicrobial activity of mucosal-associated invariant T cells 2010 · 682 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Nature Immunology
2010 Blood
2008 Immunity
2003 Nature
2002 Nature Immunology
1995 Science
1994 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Olivier Lantz

Since Specialization

Citations

This map shows the geographic impact of Olivier Lantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Lantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Lantz more than expected).

Fields of papers citing papers by Olivier Lantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Lantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Lantz. The network helps show where Olivier Lantz may publish in the future.

Co-authors

The 25 scholars most cited alongside Olivier Lantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olivier Lantz Line = papers co-authored together Olivier Lantz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Protective effect of TCR-mediated MAIT cell activation during experimental autoimmune encephalomyelitis Nature Communications ·Mark Walkenhorst, Jana K. Sonner, Nina Meurs, Jan Broder Engler, Simone Bauer, Ingo Winschel, Marcel S. Woo, Lukas Raich, Iris Winkler, Vanessa Vieira, L Unger, Gabriela Salinas, Olivier Lantz, Manuel A. Friese, Anne Willing	2024	4
2	Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study JMIR Public Health and Surveillance ·Stéphanie Bougeard, Adeline Huneau‐Salaün, Mikaël Attia, Jean‐Baptiste Richard, Caroline Demeret, Johnny Platon, V. Allain, Stéphane Le Vu, Sophie Goyard, Véronique Gillon, Sibylle Bernard-Stoecklin, Bernadette Crescenzo-Chaigne, Gabrielle Jones, Nicolas Rose, Sylvie van der Werf, Olivier Lantz, Thierry Rose, Harold Noël	2023	1
3	Contribution of resident and circulating precursors to tumor-infiltrating CD8 ⁺ T cell populations in lung cancer Science Immunology ·Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin‐Givelet, Marine Lefèvre, Thierry Mora, Aleksandra M. Walczak, Joshua J. Waterfall, Sebastián Amigorena	2021	89
4	Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy Journal for ImmunoTherapy of Cancer ·Marie Tourret, Nana Talvard-Balland, Marion Lambert, Ghada Ben Youssef, Mathieu F. Chevalier, Armelle Bohineust, Thomas Yvorra, Florence Morin, Saba Azarnoush, Olivier Lantz, Jean‐Hugues Dalle, Sophie Caillat‐Zucman	2021	23
5	In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 ⁺ T _H 1 cell response Science Immunology ·Aurélien Sutra Del Galy, Silvia Menegatti, Jaime R. Fuentealba, Francesca Lucibello, Laëtitia Perrin, Julie Helft, Aurélie Darbois, Michael Saitakis, Jimena Tosello, Derek C. Rookhuizen, Marc Deloger, Pierre Gestraud, Gèrard Socié, Sebastián Amigorena, Olivier Lantz, Laurie Menger	2021	41
6	Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity Nature Communications ·Amine Toubal, Badr Kiaf, Lucie Beaudoin, Lucie Cagninacci, Moez Rhimi, Blandine Fruchet, Jennifer Da Silva, Alexandra J. Corbett, Yannick Simoni, Olivier Lantz, Jamie Rossjohn, James McCluskey, Philippe Lesnik, Emmanuelle Maguin, Agnès Lehuen	2020	120
7	IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation Cancer Immunology Research ·Pamela Caudana, Nicolás Gonzalo Núñez, Philippe De La Rochère, Anaïs Pinto, Jordan Denizeau, Ruby Alonso, Leticia Laura Niborski, Olivier Lantz, Christine Sedlik, Eliane Piaggio	2019	17
8	A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals Microbiome ·Petar Šćepanović, Flavia Hodel, Stanislas Mondot, Valentin Partula, Allyson L. Byrd, Christian Hammer, Cécile Alanio, Jacob Bergstedt, Étienne Patin, Mathilde Touvier, Olivier Lantz, Matthew L. Albert, Darragh Duffy, Lluís Quintana‐Murci, Jacques Fellay	2019	111
9	Microbial metabolites control the thymic development of mucosal-associated invariant T cells Science ·François Legoux, Déborah Bellet, Céline Daviaud, Yara El Morr, Aurélie Darbois, Kristina Niort, Emanuele Procopio, Marion Salou, Jules Gilet, Bernhard Ryffel, Aurélie Balvay, Anne Foussier, Manal Sarkis, Ahmed El Marjou, Frédéric Schmidt, Sylvie Rabot, Olivier Lantz	2019	224
10	Associations between usual diet and gut microbiota composition: results from the Milieu Intérieur cross-sectional study American Journal of Clinical Nutrition ·Valentin Partula, Stanislas Mondot, M Torres, Emmanuelle Kesse‐Guyot, Mélanie Deschasaux, Karen E. Assmann, Paule Latino‐Martel, Camille Buscail, Chantal Julia, Pilar Galán, Serge Herçberg, Vincent Rouilly, Stéphanie Thomas, Lluís Quintana‐Murci, Matthew L. Albert, Darragh Duffy, Olivier Lantz, Mathilde Touvier	2019	62
11	Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node Nature Communications ·Ruby Alonso, Héloïse Flament, Sébastien Lemoine, Christine Sedlik, Emanuel Bottasso, Isabel Péguillet, Virginie Prémel, Jordan Denizeau, Marion Salou, Aurélie Darbois, Nicolás Gonzalo Núñez, Benoı̂t L. Salomon, David‐Alexandre Gross, Eliane Piaggio, Olivier Lantz	2018	70
12	Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes Nature Immunology ·Ophélie Rouxel, Jennifer Da Silva, Lucie Beaudoin, Isabelle Nel, Céline Tard, Lucie Cagninacci, Badr Kiaf, Masaya Oshima, Marc Diedisheim, Marion Salou, Alexandra J. Corbett, Jamie Rossjohn, James McCluskey, Raphaël Scharfmann, Manuela Battaglia, Michel Polak, Olivier Lantz, Jacques Beltrand, Agnès Lehuen	2017	184
13	Blood monocytes sample MelanA/MART1 antigen for long‐lasting cross‐presentation to CD8⁺T cells after differentiation into dendritic cells International Journal of Cancer ·Florence Faure, Mabel Jouve, Isabelle Lebhar-Peguillet, Charlotte Sadaka, Fernando E. Sepulveda, Olivier Lantz, Stefano Berrè, Raphaël Gaudin, Silvia Sánchez‐Ramón, Sebastián Amigorena	2017	14
14	MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Immunogenetics ·Stanislas Mondot, Pierre Boudinot, Olivier Lantz	2016	43
15	High Numbers of Differentiated Effector CD4 T Cells Are Found in Patients with Cancer and Correlate with Clinical Response after Neoadjuvant Therapy of Breast Cancer Cancer Research ·Isabelle Péguillet, Maud Milder, Delphine Louis, Anne Vincent‐Salomon, Thierry Dorval, Sophie Piperno‐Neumann, Suzy Scholl, Olivier Lantz	2014	29
16	Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma Clinical Cancer Research ·Jordan Madic, Sophie Piperno‐Neumann, Vincent Servois, Aurore Rampanou, Maud Milder, Bénédicte Trouiller, David Gentien, Stéphanie Saada, Franck Assayag, Aurélie Thuleau, Fariba Némati, Didier Decaudin, François‐Clément Bidard, Laurence Desjardins, Pascale Mariani, Olivier Lantz, Marc‐Henri Stern	2012	65
17	Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells PLoS Biology ·Marielle C. Gold, Stefania Cerri, Susan Smyk‐Pearson, Meghan Cansler, Todd M. Vogt, Jacob Delepine, Ervina Winata, Gwendolyn Swarbrick, Wei‐Jen Chua, Yik Y. L. Yu, Olivier Lantz, Matthew S. Cook, Megan Null, David B. Jacoby, Melanie J. Harriff, Deborah A. Lewinsohn, Ted H. Hansen, David Lewinsohn	2010	493
18	Antigen-specific T-T interactions regulate CD4 T-cell expansion Blood ·Julie Helft, Alexandra Jacquet, Nathalie T. Joncker, Isabelle Grandjean, Guillaume Dorothée, Adrien Kissenpfennig, Bernard Malissen, Polly Matzinger, Olivier Lantz	2008	54
19	A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression Journal of Translational Medicine ·Erika M. von Euw, María Marcela Barrio, David Furman, Estrella Mariel Levy, Michele Bianchini, Isabelle Péguillet, Olivier Lantz, Alejandra Vellice, Abraham I. Kohan, Matías Chacón, Cassian Yee, Rosa Wainstok, José Mordoh	2008	58
20	Anti-LFA-1 Antibody Postpones T-cell Receptor Triggering While Preserving Generation of Regulatory T Cells in T-cell Receptor Anti-HY Transgenic Mice Transplantation ·Seitetsu Go, Audrey Fleischmann, Olivier Lantz, Célia Cretolle, Nicole Brousse, Nadine Cerf–Bensussan, Sabine Sarnacki	2006	3

About Olivier Lantz

Olivier Lantz is a scholar working on Transplantation, Immunology, Virology, Oncology and Cancer Research, having authored 213 papers that have together received 16.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (109 papers), T-cell and B-cell Immunology (93 papers), Immunotherapy and Immune Responses (59 papers), Renal Transplantation Outcomes and Treatments (19 papers), IL-33, ST2, and ILC Pathways (18 papers), CAR-T cell therapy research (16 papers), Cancer Genomics and Diagnostics (16 papers) and Cytomegalovirus and herpesvirus research (15 papers). The work is most often cited by research in Immunology (12.5k citations), Oncology (3.1k citations), Cancer Research (1.6k citations), Virology (419 citations) and Epidemiology (2.1k citations). Olivier Lantz has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Albert Bendelac, Emmanuel Treiner, Livine Duban, Emmanuel Martin, Lionel Le Bourhis, Claire Soudais, Florence Tilloy, Virginie Prémel, Clotilde Théry and Polly Matzinger. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Cancer Research, European Journal of Immunology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact